BioSpace News Archive

Business

Tempus Announces Companion Diagnostic Collaboration with Kartos Therapeutics

Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration to develop a companion diagnostic (CDx) test with Kartos Therapeutics, a clinical stage biopharmaceutical company, in support of its ongoing Phase II study of navtemadlin (KRT-232).

October 6, 2022
·
3 min read
Chronic Pain Treatment Market Major Companies, Growth Strategies and New Trends By 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Chronic Pain Treatment Market – Forecast to 2030,’ thoroughly examines the Chronic Pain Treatment industry to provide essential data & information for the targeted readers.

October 6, 2022
·
6 min read
Human Papillomavirus Treatment Market Future Growth Prospect, Industry Trends and Demand Analysis Till 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Human Papillomavirus Treatment Market – Forecast to 2030,’ thoroughly examines the Human Papillomavirus Treatment industry to provide essential data & information for the targeted readers.

October 6, 2022
·
6 min read
Plague Market Witness Astonishing Growth Forecast to 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Plague Market – Forecast to 2030,’ thoroughly examines the Plague industry to provide essential data & information for the targeted readers.

October 6, 2022
·
6 min read
Sensorion to Present at the European Society of Gene & Cell Therapy (ESGCT) and the Gene Therapy for Rare Disorders Europe conferences in October 2022

Sensorion is pleased to announce Sensorion’s participation in two scientific conferences in October 2022.

October 6, 2022
·
4 min read
Dipharma Receives Regulatory Authorization for the New Line at Its cGMP Pilot Plant

Dipharma Francis S.r.l. announced that the Italian Medicines Agency approved the brand-new production line at the cGMP pilot plant suite, located in its facility of Mereto di Tomba.

October 6, 2022
·
3 min read
Largest study measuring extent of COVID-19 in Canadian children and teens now underway

In Canada, the vast majority of COVID-19 cases in the 0 to 18 age group have been mild or asymptomatic. This fact, combined with the reduction in routine COVID-19 laboratory testing across most of the country, means that the infection rates in children and adolescents are largely unknown.

October 6, 2022
·
4 min read
Policy

First Adaptive Hemorrhagic Stroke Trial Completes Enrollment

NICO Corporation announced that enrollment is now complete for the ENRICH randomized controlled trial.

October 6, 2022
·
3 min read
Biotech Beach

Hugel Aesthetics Resubmits Biologics License Application for LetibotulinumtoxinA for Injection for Glabellar Lines to the FDA

Hugel America, Inc. (Hugel Aesthetics) announced today that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for letibotulinumtoxinA for Injection for the treatment of moderate to severe glabellar lines.

October 6, 2022
·
1 min read
BioCapital

Parallel ENT & Allergy Partners Adds Grand Rapids ENT of Michigan to Provide Expanded and Improved Patient Care

Parallel ENT & Allergy Partners has added a second state to its roster of high-quality, innovative ENT and allergy partners with the addition of Grand Rapids ENT.

October 6, 2022
·
3 min read